ACXP 8-K: Board change

Filed with the SEC on · accession 0001104659-26-127104

ACXP filed a 8-K (current report) with the SEC on Nov 13, 2026. Joseph C. Scodari, a member of Acurx Pharmaceuticals' Board of Directors since 2021, notified the company of his intention to retire from the Board effective November 13, 2026. The stock moved -2.5% by the first close after the filing.

Summary of the filing

Joseph C. Scodari, a member of Acurx Pharmaceuticals' Board of Directors since 2021, notified the company of his intention to retire from the Board effective November 13, 2026. His decision was not due to any disagreement with the company, and he has agreed to continue serving as a corporate advisor.

Key details

RegistrantAcurx Pharmaceuticals, Inc.
Board memberJoseph C. Scodari
President and chief executive officerDavid P. Luci

How ACXP stock reacted

Close before

$0.98

Nov 12, 2026

First close after

-2.54%

$0.96

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for ACXP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ACXP?

Click here

Frequently asked questions

What did ACXP file with the SEC on Nov 13, 2026?

ACXP filed a 8-K (Board change). Joseph C. Scodari, a member of Acurx Pharmaceuticals' Board of Directors since 2021, notified the company of his intention to retire from the Board effective November 13, 2026. His decision was not due to any disagreement with the company, and he has agreed to continue serving as a corporate advisor.

What does a board change mean for ACXP stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did ACXP stock react to this filing?

ACXP closed at $0.98 before the filing and $0.96 on Nov 13, 2026 (-2.54%).

Other ACXP SEC filings

Get alerts when ACXP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days